| 1 |
Gene expression profiling of HDLM-2 Hodgkin ...
|
Homo sapiens
|
Homo sapiens |
| Cell |
HDLM2 |
| Perturbation |
Sorafenib |
| Time |
24hrs |
| Concentration |
5uM |
| Disease |
Hodgkin lymphoma |
|
| 2 |
Gene expression profiling of L-540 Hodgkin ...
|
Homo sapiens
|
Homo sapiens |
| Cell |
L540 |
| Perturbation |
Sorafenib |
| Time |
24hrs |
| Concentration |
5uM |
| Disease |
Hodgkin lymphoma |
|
| 3 |
Gene expression profiling of HD-MyZ Hodgkin ...
|
Homo sapiens
|
Homo sapiens |
| Cell |
HDMyZ |
| Perturbation |
Sorafenib |
| Time |
24hrs |
| Concentration |
5uM |
| Disease |
Hodgkin lymphoma |
|
| 4 |
Gene expression analysis of Hodgkin lymphoma ...
|
Homo sapiens
|
Homo sapiens |
| Cell |
HDLM2 |
| Perturbation |
Sorafenib |
| Time |
5uM |
| Concentration |
24hrs |
| Disease |
Hodgkin lymphoma |
|
| 5 |
Sorafenib treatment of FLT3-ITD+ acute myeloid ...
|
Homo sapiens
|
Homo sapiens |
| Cell |
CD33+CD34+ myeloblast |
| Perturbation |
Sorafenib |
| Time |
Twice daily |
| Concentration |
200-400mg |
| Disease |
AML |
|
| 6 |
Gene expression profiling of HDLM-2 Hodgkin ...
|
Homo sapiens
|
Homo sapiens |
| Cell |
HDLM2 |
| Perturbation |
Sorafenib |
| Time |
24hrs |
| Concentration |
5uM |
|
| 7 |
Gene expression profiling of L-540 Hodgkin ...
|
Homo sapiens
|
Homo sapiens |
| Cell |
L540 |
| Perturbation |
Sorafenib |
| Time |
24hrs |
| Concentration |
5uM |
|
| 8 |
GSE43053 - The multikinase inhibitor Sorafenib ...
|
Rattus norvergicus
|
Rattus norvergicus |
| Cell |
LCSC-2 |
| Perturbation |
Sorafenib |
| Disease |
Hepatocholangiocarcinoma |
|
| 9 |
Synthetic lethal screening with small molecule ...
|
Homo sapiens
|
Homo sapiens |
| Cell |
VMM39 (mutant Ras) |
| Perturbation |
Sorafenib |
|
| 10 |
Effective sorafenib treatment response in a ...
|
Homo sapiens
|
Homo sapiens |
|
